IBL HealthCare Share Price, PSX Chart & Forecast (PSX: IBLHL) IBL HealthCare Limited

PSX: IBLHL Pharmaceuticals Shariah compliant Model: Strongly bearish

Rs39.63

Down −0.26 (−0.65%) on the day

As of Tue, 27 Oct 2026 close · Source: PSX · End-of-day data, not a live feed

☆ Add to watchlist Set price alert ⇄ Compare

IBLHL key statistics

Session of 27 Oct 2026 · Select ? beside a label for a plain-English definition

OpenOpenThe price of the first trade in the session. Glossary: Rs 40.99
HighHighThe highest price traded during the period — today's session unless stated otherwise. Glossary: Rs 40.99
LowLowThe lowest price traded during the period — today's session unless stated otherwise. Glossary: Rs 39.50
Prev closeCloseThe official last price of the session. The day's change is measured from the previous close, and it is the reference for the next session. Glossary: Rs 39.89
VolumeVolumeThe number of shares traded in the session. A move on heavy volume carries more conviction than the same move on a quiet day. Glossary: 27,178
TurnoverTurnoverThe rupee value of shares traded (volume × price). Pakistani market reports often use "turnover" loosely for the number of shares traded, so check the unit. Glossary: Rs 1.1M
Market capMarket capitalisationShare price multiplied by the number of shares outstanding — what the market says the whole company is worth. Use it, not the share price, to compare the size of two businesses. Glossary: Rs 3.90B
P/E ratioP/E ratioShare price divided by earnings per share — how many rupees you pay for one rupee of annual profit. Compare it only with companies in the same sector. Glossary: 17.7
EPSEPS (earnings per share)Net profit divided by shares outstanding — the company's earnings attributable to one share. Rising EPS over several years is the cleanest evidence a business is growing. Glossary: Rs 2.24
Dividend yieldDividend yieldAnnual dividend per share divided by the share price, as a percentage. A very high yield is often a warning: the price may have fallen sharply, and the dividend may be cut next. Glossary: —
BetaBetaHow much a stock tends to move relative to the market. A beta of 1 moves with it, above 1 amplifies it, below 1 dampens it — it measures co-movement, not quality. Glossary: 1.12
ROEROE (return on equity)Net profit as a percentage of shareholders' equity — how efficiently management turns the owners' capital into profit. Consistently high ROE without heavy debt is a sign of a durable business. Glossary: —
Book value / shareBook valueAssets minus liabilities — the company's accounting net worth, usually quoted per share. Glossary: —
P/B ratioP/B (price-to-book)Share price divided by book value per share. Below 1 means the market values the company at less than its stated net assets — a reason to investigate, not an automatic bargain. Glossary: —
52-week range52-week rangeThe lowest and highest price over the past year. It shows where today's price sits, but a stock near its 52-week low is not automatically cheap. Glossary: 37.3339.6380.28

— means not available. For IBLHL that is dividend yield, as no cash dividend from the past twelve months is on file; ROE, book value and P/B, which need audited accounts we do not hold yet. We leave a figure blank rather than estimate it.

IBLHL at a glance

What the figures on this page say, in plain English

Strengths

Nothing in the data on this page reads as a clear strength today.

Cautions

Thinly traded. Only Rs 1.1 million changed hands in the last session, so a few orders can move the price.
Downtrend. Trades below its 20-day (Rs 40.92) and 50-day (Rs 43.40) moving averages.
Near its 52-week low. Trades 6.2% above its 52-week low of Rs 37.33.
Model reads bearish. The automated model reads IBLHL as bearish at 45% confidence.

What this means: each line restates a figure for IBLHL shown on this page and is recomputed after every session. It describes the data; it is not a recommendation to buy or sell.

Model outlook

rule-engine-v2

Strongly bearishAI signalThe model's directional reading of the stock over the next ten sessions, on a five-step scale from strongly bearish to strongly bullish, built from price and indicator history. A description of the data, not investment advice. Glossary

45% confidenceConfidenceHow strongly the model leans toward its call. It is not the probability of being right — the graded record against the base rate is the figure for that. Glossary · Short Term

The model reads IBLHL as strongly bearish — an overall score of 39/100 from the rule-based fallback, which is a blend of inputs, not a probability. See the graded record and what drove it ↓

Automated model output, not a recommendation. A reading is a statistical lean; weigh it against the live record in the model card.

IBLHL price chart

Daily IBLHL prices with 20- and 50-day averages and Bollinger Bands. Drag to zoom; hover for each day's figures.

Price SMA 20 SMA 50 Bollinger Bands Volume, up / down day

27 Oct 2025 – 27 Oct 2026: ▼ −16.71% · high Rs 80.28 · low Rs 37.33

IBLHL share price and analysis

IBL HealthCare Limited (IBLHL) last traded at Rs 39.63 on the Pakistan Stock Exchange, where it fell 0.65% on the session of 27 October 2026. Turnover was thin at 27,178 shares, a turnover of Rs 1.1 million, so the closing price rests on a small number of trades. Over the past year the share has traded between Rs 37.33 and Rs 80.28, putting the current price close to its 12-month low.

The price sits below both its 20-day (40.92) and 50-day (43.40) moving averages, which is the configuration usually read as a downtrend. The 14-day RSI is 36.8, a neutral reading. ADX at 27.2 indicates a trending market rather than a range.

The company is capitalised at roughly Rs 3.9 billion and is classified under Pharmaceuticals. It trades on a price-to-earnings ratio of 17.7, meaning the market is paying about Rs 17.7 for every rupee of annual earnings. Earnings per share stand at Rs 2.24. A beta of 1.12 against the KSE-100 means the share has moved more sharply than the wider market over the past year.

IBLHL ranks 18th of 34 Pharmaceuticals companies by market value. Its price-to-earnings ratio of 17.7 compares with the Pharmaceuticals median of 16.1, a modest premium to its sector. Sector medians are taken across the companies we hold fundamentals for and move as those are restated.

Our forecasting model currently reads IBLHL as strongly bearish over a short term horizon, at 45% confidence. The model is computed from the price and indicator history shown on this page. It does not read news, financial statements or management changes, and it is not a recommendation to buy or sell.

This summary is generated from the end-of-day prices and indicators shown on this page and is refreshed after each trading session. It describes the data; it is not a recommendation. See how we collect and check this data and our disclaimer.

IBLHL model outlook & accuracy

rule-engine-v2

Model: Strongly bearish 45% confidenceConfidenceHow strongly the model leans toward its call. It is not the probability of being right — the graded record against the base rate is the figure for that. Glossary · Short Term

Live graded record

Too few graded calls on IBLHL to quote alone. Across all stocks, 58.6% of 4,564 graded calls were right, against a 67.2% base rate. The model is not currently beating that base rate. Full record

In-sample backtest on IBLHL: 58.3% over 187 past dates — an upper bound, not a forecast record.Backtested accuracyHow often the model's direction call would have been right on past data, rather than on live published calls. Backtests flatter almost every model — most of all on the history it was fitted to — so treat it as an upper bound, not an expectation. Glossary

Trend7/100

Momentum68/100

Value50/100

Stability53/100

Overall39/100

SupportSupport and resistancePrice levels where buying (support) or selling (resistance) has repeatedly stopped a move before. They are zones drawn from history, not guarantees. Glossary: Rs 39.50
Resistance: Rs 42.64
Risk: 53/100

Why

The model reads IBLHL as strongly bearish: its inputs line up on the downside. Overall score 39/100. Drivers: Price below the 50-day average (downtrend); Histogram positive — momentum building; Oversold (%K 6); Strong trend (ADX 27). Note the tension: the indicators below currently read bullish, so this reading rests on the model's weighting rather than on momentum agreeing with it — treat it with more caution than usual. This is an automated model reading, not financial advice.

Generated by rule-engine-v2 from the indicators above. It does not read news, filings or management changes — see how this works.

Other Pharmaceuticals stocks

IBLHL is a Pharmaceuticals listing. Compare it against the rest of the sector, or read what actually drives Pharmaceuticals companies on the PSX.

All Pharmaceuticals shares on the PSX →

Learn how to read this page

How to Read a Stock Page Without Fooling Yourself
A walk through every number on a PSX stock page — price, volume, P/E, RSI, our own AI signal — and an honest account of how much weight each one deserves.
Technical Analysis on the PSX: Using Moving Averages, RSI and MACD Without Fooling Yourself
Moving averages, RSI and MACD describe past prices — nothing more. Used in the right order they keep you honest; used as signals they lose money. Here are the mechanics that actually work on the PSX, and where thin volume and circuit breakers make indicators meaningless.
How to Read a PSX Company's Financial Statements
Annual reports are free, audited and almost never read. A walk through a PSX income statement and balance sheet, with EPS, P/E, ROE and dividend yield worked by hand — and the red flags those ratios quietly hide.

All investing guides →

IBLHL technical indicators — RSI, MACD & moving averages

Momentum and trend gauges for IBLHL after the session of 27 Oct 2026, each with a one-line reading of what the number means.

RSI (14)

RSI (Relative Strength Index)A momentum gauge from 0 to 100, usually over 14 days. Above 70 is called overbought and below 30 oversold, but in a strong trend RSI can stay there for weeks — it is not a buy or sell instruction. Glossary

IBLHL reads 36.8 — neutral (between 30 and 70). Above 70 is conventionally read as overbought, below 30 as oversold; dashed lines mark both.

MACD (12, 26, 9)

MACDThe 12-day exponential moving average minus the 26-day, with a 9-day signal line on top. A cross above the signal line means short-term momentum has turned up; it lags, and misfires in sideways markets. Glossary

IBLHL reads -0.995 — above its signal line: momentum improving. Bars show the gap between MACD and its signal line.

RSI (14): 36.8; Neutral (between 30 and 70)
Stochastic %K: 5.8; Oversold zone (below 20)
ADX (14)ADX (Average Directional Index)Measures trend strength from 0 to 100 without saying which direction. Below about 20 the market is ranging; above 25 a real trend is present. Glossary: 27.2; Trending market (25 or above)
Williams %R: -94.2; Oversold zone (below −80)
SMA 20SMA 20The average closing price of the last 20 sessions, redrawn each day — a short-term trend line. Moving averages describe what has happened; they do not predict. Glossary: 40.92; Price is 3.2% below it
SMA 50SMA 50The average closing price of the last 50 sessions — the most watched medium-term trend line. Price above a rising 50-day average is a common definition of an uptrend. Glossary: 43.40; Price is 8.7% below it
MACD: -0.995; Above its signal line: momentum improving
ATR (14): 0.656; A typical day moves about 1.7% of the price
Bollinger upperBollinger BandsA moving average with bands two standard deviations above and below; they widen as volatility rises. Touching the upper band means the price is stretched, not that it must reverse. Glossary: 42.52; Price is 6.8% below it
Bollinger lower: 39.32; Price is 0.8% above it
Momentum (10): -0.91; Lower than 10 sessions ago
Technical score: 34; Weak, on a 0–100 scale

IBLHL fundamentals & valuation ratios

Set beside the median Pharmaceuticals company

IBL HealthCare Limited (IBLHL) valuation ratios against the Pharmaceuticals sector median
Measure	IBLHL	Sector median
Market cap	Rs 3.90B	No. 18 of 34 by size
P/E ratio	17.7	16.1
EPS	Rs 2.24	—
P/B ratio	—	—
Dividend yield	—	—
ROE	—	—
Beta	1.12	—
Volatility (annualised)	46.9%	—

Fundamental score

50/100

What this means: IBLHL scores 50 on a 0–100 check built only from the figures we hold for it — P/E and volatility. 50 is neutral; compare it within a sector, not across sectors. A dash in the table is a figure we do not hold for IBLHL; it adds nothing to the score rather than being guessed.

IBLHL price history — last 30 sessions

Daily open, high, low and close, newest first

IBL HealthCare Limited (IBLHL) daily open, high, low, close and volume on the Pakistan Stock Exchange
Date	Open	High	Low	Close	Change	Volume
Tue, 27 Oct 2026	40.99	40.99	39.50	39.63	▼ −0.65%	27,178
Mon, 26 Oct 2026	39.61	39.89	39.61	39.89	▲ +0.71%	44,866
Fri, 23 Oct 2026	40.15	40.15	39.61	39.61	▼ −1.35%	27,907
Thu, 22 Oct 2026	41.23	41.23	40.15	40.15	▼ −2.62%	70,186
Wed, 21 Oct 2026	40.28	41.23	40.28	41.23	▲ +2.36%	32,669
Tue, 20 Oct 2026	41.07	41.07	40.28	40.28	▼ −1.92%	9,973
Mon, 19 Oct 2026	41.37	41.37	41.07	41.07	▼ −0.73%	24,791
Fri, 16 Oct 2026	41.46	41.46	41.37	41.37	▼ −0.22%	74,194
Thu, 15 Oct 2026	40.90	41.46	40.90	41.46	▲ +1.37%	219,828
Wed, 14 Oct 2026	40.54	40.90	40.54	40.90	▲ +0.89%	61,112
Tue, 13 Oct 2026	40.40	40.54	40.40	40.54	▲ +0.35%	12,048
Mon, 12 Oct 2026	41.12	41.12	40.40	40.40	▼ −1.75%	36,961
Fri, 9 Oct 2026	41.03	41.12	41.03	41.12	▲ +0.22%	19,791
Thu, 8 Oct 2026	41.76	41.76	41.03	41.03	▼ −1.75%	26,614
Wed, 7 Oct 2026	41.05	41.76	41.05	41.76	▲ +1.73%	16,824
Tue, 6 Oct 2026	40.40	41.05	40.40	41.05	▲ +1.61%	47,173
Mon, 5 Oct 2026	41.63	41.63	40.40	40.40	▼ −2.95%	31,551
Fri, 2 Oct 2026	42.25	42.25	41.63	41.63	▼ −1.47%	27,155
Thu, 1 Oct 2026	42.64	42.64	42.25	42.25	▼ −0.91%	47,786
Wed, 30 Sep 2026	42.24	42.64	42.24	42.64	▲ +0.95%	40,336
Tue, 29 Sep 2026	42.52	42.52	42.24	42.24	▼ −0.66%	60,359
Mon, 28 Sep 2026	42.93	42.93	42.52	42.52	▼ −0.96%	79,766
Fri, 25 Sep 2026	43.44	43.44	42.93	42.93	▼ −1.17%	85,740
Thu, 24 Sep 2026	44.94	44.94	43.44	43.44	▼ −3.34%	125,398
Wed, 23 Sep 2026	45.23	45.23	44.94	44.94	▼ −0.64%	573,491
Tue, 22 Sep 2026	43.65	45.23	43.65	45.23	▲ +3.62%	106,384
Mon, 21 Sep 2026	43.68	43.68	43.65	43.65	▼ −0.07%	19,969
Fri, 18 Sep 2026	42.04	43.68	42.04	43.68	▲ +3.90%	107,885
Thu, 17 Sep 2026	42.02	42.04	42.02	42.04	▲ +0.05%	57,105
Wed, 16 Sep 2026	42.89	42.89	42.02	42.02	▼ −2.03%	39,847

All figures in PKR, end of day, sourced from the Pakistan Stock Exchange.

IBLHL — frequently asked questions

What is IBLHL's share price today?

IBL HealthCare Limited (IBLHL) last traded at Rs 39.63 on the Pakistan Stock Exchange, down 0.65% on the session of 27 October 2026. The day's range was Rs 39.50 to Rs 40.99 on 27,178 shares. These are end-of-day figures published by the exchange, not a live trading feed.

What is the 52-week high and low for IBLHL on the PSX?

IBLHL has traded between Rs 37.33 and Rs 80.28 over the past twelve months on the Pakistan Stock Exchange. The range is computed from the end-of-day closes we hold for the stock and is refreshed after every session.

Is IBLHL Shariah-compliant on the PSX?

Yes. The Pakistan Stock Exchange lists IBLHL in its Shariah-screened KMI All Share index, which means the company passed the screening set with Meezan Bank at the last review — the business-activity test plus the financial ratio tests on interest-bearing debt, illiquid assets and non-compliant income. Screening is periodic, so a company can be dropped when a ratio breaks; check the current KMI index membership before relying on it.

Which PSX indices is IBLHL part of?

IBLHL is a constituent of the KSE All Share and KMI All Share. It is not in the KSE-100, the headline PSX benchmark. Index membership is taken from the exchange's own published listing for each session.

Is IBLHL expensive? What are its valuation ratios?

IBLHL trades on a price-to-earnings ratio of 17.7, so the market is paying about Rs 17.7 for each rupee of annual earnings and earnings per share of Rs 2.24. Ratios are only meaningful next to the rest of the sector — a low multiple that the whole sector shares is usually a sector problem rather than a bargain, which is why the sector page is linked from this one.

What is the model outlook for IBLHL?

Our model currently reads IBLHL as strongly bearish over a short term horizon, at 45% confidence. It is computed from this stock's own price and indicator history. It does not read news, financial statements or management changes, its graded record against the base rate is published on the page, and it is not investment advice.

Answers are generated from the end-of-day figures on this page and refreshed after each session. See all frequently asked questions or our methodology.

About this data

Prices, volumes and indicators for IBLHL are end-of-day figures collected from the Pakistan Stock Exchange and recomputed after each session — they are not a live trading feed and may lag the market. Forecasts are the output of logistic-v1, an automated logistic-regression model trained on price history alone; it does not read news, filings or management changes, no analyst reviews its output before publication, and its track record is published in full on our model accuracy page.

PSX Expert is an independent analytics publisher. We are not licensed by the SECP as a securities adviser, investment adviser, research analyst or broker-dealer, and nothing on this page is a personal recommendation. Past performance and back-tested results do not predict future results. Read our methodology, who we are and the full disclaimer before acting on anything here.